Latest Schedule 13G passive stakes

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 3.5% of Bold Eagle Acquisition Corp.'s Class A ordinary shares as of June 30, 2026.

Laurence W. Lytton has filed a Schedule 13G, reporting beneficial ownership of 9.99% of Guerrilla RF, Inc.'s common stock, including shares and warrants.

LaSalle Investment Management Securities LLC has reported beneficial ownership of 7.6% of National Healthcare Properties, Inc. common stock.

AQR Capital Management, LLC and AQR Capital Management Holdings, LLC have filed an amendment to their Schedule 13G, reporting their beneficial ownership of Boston Beer Co Inc Class A Common Stock.

Ashford Capital Management, Inc. has filed a Schedule 13G, reporting beneficial ownership of 4.9% of Vox Royalty Corp.'s common shares as of June 30, 2026.

AQR Capital Management, LLC and AQR Capital Management Holdings, LLC have filed an amendment to their Schedule 13G, reporting beneficial ownership of 6.93% of SentinelOne, Inc.'s Class A common stock as of June 30, 2026.

AQR Capital Management, LLC and AQR Capital Management Holdings, LLC have amended their Schedule 13G filing to report beneficial ownership of 5.59% of Selective Insurance Group Inc.'s common stock.

AQR Capital Management, LLC and AQR Capital Management Holdings, LLC have disclosed beneficial ownership of over 5% of Sarepta Therapeutics, Inc. common stock, acquiring 5,329,691 shares.

Ashford Capital Management, Inc. has amended its Schedule 13G filing to report beneficial ownership of 4.2% of ReposiTrak, Inc.'s common shares as of June 30, 2026.

AQR Capital Management, LLC and AQR Capital Management Holdings, LLC have filed a Schedule 13G, reporting beneficial ownership of 5.02% of Repay Holdings Corp's Class A Common Stock.

AQR Capital Management, LLC and AQR Capital Management Holdings, LLC have filed an amendment to their Schedule 13G, reporting a beneficial ownership of 6.83% in Molina Healthcare, Inc.

ARGA Investment Management LP and Avula Rama Krishna have jointly filed a Schedule 13G, disclosing beneficial ownership of 5.9% of XP Inc.'s Class A common shares as of June 30, 2026.

Staley Capital Advisers, Inc. and its associated individuals have updated their Schedule 13G filing, reporting beneficial ownership of 0.7% to 1.1% of Liquidity Services Inc. common stock as of June 30, 2026.

Several Manchester entities and individuals have updated their beneficial ownership filings for EUPRAXIA PHARMACEUTICALS INC. common shares, with aggregate holdings now reported.

A Schedule 13G filing for Globavend Holdings Ltd details the beneficial ownership of ordinary shares by Ayrton Capital LLC, Alto Opportunity Master Fund, SPC, and Waqas Khatri.

Canadian Imperial Bank of Commerce has disclosed beneficial ownership of 7.3% of DraftKings Inc. common stock as of June 30, 2026.

Canadian Imperial Bank of Commerce has disclosed beneficial ownership of 7.3% of DraftKings Inc. common stock as of June 30, 2026.

A filing reveals Ayrton Capital LLC, Alto Opportunity Master Fund, SPC, and Waqas Khatri collectively hold a 1.59% stake in GeoVax Labs, Inc. through warrants.

Ayrton Capital LLC, along with its associated entities, has disclosed an 8.14% ownership stake in ESS Tech, Inc., primarily through common stock and exercisable warrants.

BNP Paribas SA has disclosed beneficial ownership of 15,305,255 shares, representing 8.87% of Krispy Kreme Inc.'s common stock, as of June 30, 2026.

Ayrton Capital LLC, along with Alto Opportunity Master Fund and Waqas Khatri, has reported beneficial ownership of 2,087,905 shares, representing 2.12% of Merlin, Inc.'s common stock.

Janus Henderson Group Ltd. has disclosed beneficial ownership of 5,909,184 shares, representing 9.7% of Mirum Pharmaceuticals, Inc.'s common stock, as of June 30, 2026.

Janus Henderson Group Ltd. has disclosed beneficial ownership of 5,909,184 shares, representing 9.7% of Mirum Pharmaceuticals, Inc.'s common stock, as of June 30, 2026.

Janus Henderson Group Ltd. has updated its beneficial ownership filing for Forte Biosciences, Inc., reporting a 9.3% stake as of June 30, 2026.

Janus Henderson Group Ltd. has updated its beneficial ownership filing for Forte Biosciences, Inc., reporting a 9.3% stake as of June 30, 2026.

Janus Henderson Group Ltd. has disclosed beneficial ownership of 1,359,514 shares, representing 6.9% of the outstanding common stock of Assembly Biosciences, Inc.

Janus Henderson Group Ltd. has disclosed beneficial ownership of 1,359,514 shares, representing 6.9% of the outstanding common stock of Assembly Biosciences, Inc.

Janus Henderson Group Ltd. has amended its Schedule 13G filing, reporting a decrease in its beneficial ownership of Tarsus Pharmaceuticals, Inc. common stock to 6.5%.

Janus Henderson Group Ltd. has amended its Schedule 13G filing, reporting a decrease in its beneficial ownership of Tarsus Pharmaceuticals, Inc. common stock to 6.5%.

Ayrton Capital LLC, along with its affiliates, has reported beneficial ownership of 5,319,149 shares of Fingermotion Inc. common stock, representing 7.99% of the class.